克罗恩病中的Nod2突变增强了NF-kappaB活性和IL-1β处理
Shin Maeda1, Li-Chung Hsu, Hongjun Liu
1Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0723, USA.
Science (New York, N.Y.)
|February 5, 2005
概括
与克罗恩病相关的NOD2变异增强了细菌感应,导致炎症增加. 这项研究揭示了NOD2积极调节免疫反应,影响互白素-1β分泌和对肠道炎症的敏感性.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
背景情况:
- NOD2变异与克罗恩病 (CD) 易感性增加有关.
- 这些变体矛盾地与CD患者的核因子kappaB (NF-kappaB) 活性升高有关,尽管存在理论上的缺陷.
- 在先天免疫和肠道炎症中NOD2的确切作用尚不清楚.
研究的目的:
- 为了研究NOD2变体在对细菌刺激的反应中的病理生理作用.
- 在体内阐明NOD2在调节NF-kappaB激活和细胞因子分泌中的作用.
- 为了确定NOD2变异对细菌诱导的肠道炎症敏感性的影响.
主要方法:
- 产生了一种小鼠模型,该小鼠模型具有一种特定的NOD2变异,该变异被引入了内源的Nod2位点.
- 用muramyl dipeptide (MDP) 刺激突变小鼠,这是一种来自细菌的NOD2.2的配体.
- 评估NF-kappaB激活,互白素-1β (IL-1β) 处理和分泌以及肠道炎症.
主要成果:
- 突变小鼠在MDP刺激时表现出较高的NF-kappaB激活.
- 在突变小鼠中观察到促进炎症性细胞因子IL-1beta的增强处理和分泌.
- NOD2变体表达与增加对细菌诱导的肠道炎症的敏感性相关.
结论:
- NOD2作为NF-kappaB激活和IL-1β分泌的积极调节剂.
- 功能障碍的NOD2变体通过增强这些免疫反应,导致肠道炎症.
- 这些发现为克罗恩病的发病过程提供了新的见解.
相关概念视频
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...